Lopimune Lopinavir + Ritonavir

Rated 1.00 out of 5 based on 1 customer rating
(1 customer review)

Lopimune, Kaletra, Aluvia (lopinavir and Ritonavir tablet) used

Lopimune, Kaletra, Aluvia (lopinavir and ritonavir tablets) is a fixed-dose combination for the treatment of human immunodeficiency virus (HIV) infection in adults and children older than 6 months. Lopimune, Kaletra, Aluvia (lopinavir and ritonavir tablets) used in combination with other drugs that have different mechanisms of action for the components in Lopimune, Kaletra, Aluvia (lopinavir and Ritonavir tablet), and are used to treat patients with HIV infection which or have already received treatment with other drugs to treat HIV or as a first-line therapy for the treatment of patients inexperienced. HIV weakens the immune system, attacking specific immune cells, called CD4 + cells, which are involved in fighting infection, and it can lead to life-threatening opportunistic infections (infections that are usually not harmful); In addition, if too many CD4 + cells are destroyed, it can lead to acquired immunodeficiency syndrome (AIDS). Lopimune, Kaletra, Aluvia (lopinavir and Ritonavir tablet) prevent or slow HIV ability to multiply and spread, which keeps the virus quantity down to a low level, and this leads to an increase in the number of people CD4 + cells, so that the immune system It can recover, which reduces the risk of disease progression.

Category:

Description

Lopimune, Kaletra, Aluvia (lopinavir and Ritonavir tablet) used

Lopimune, Kaletra, Aluvia (lopinavir and ritonavir tablets) is a fixed-dose combination for the treatment of human immunodeficiency virus (HIV) infection in adults and children older than 6 months. Lopimune, Kaletra, Aluvia (lopinavir and ritonavir tablets) used in combination with other drugs that have different mechanisms of action for the components in Lopimune, Kaletra, Aluvia (lopinavir and Ritonavir tablet), and are used to treat patients with HIV infection which or have already received treatment with other drugs to treat HIV or as a first-line therapy for the treatment of patients inexperienced. HIV weakens the immune system, attacking specific immune cells, called CD4 + cells, which are involved in fighting infection, and it can lead to life-threatening opportunistic infections (infections that are usually not harmful); In addition, if too many CD4 + cells are destroyed, it can lead to acquired immunodeficiency syndrome (AIDS). Lopimune, Kaletra, Aluvia (lopinavir and Ritonavir tablet) prevent or slow HIV ability to multiply and spread, which keeps the virus quantity down to a low level, and this leads to an increase in the number of people CD4 + cells, so that the immune system It can recover, which reduces the risk of disease progression.

Lopimune, Kaletra, Aluvia (lopinavir and Ritonavir tablet) work

Lopimune, Kaletra, Aluvia (lopinavir and Ritonavir tablet) comprise lopinavir and ritonavir, which are inhibitors of HIV protease, and are only effective against RNA viruses (retroviruses), as human immunodeficiency virus (HIV). Retroviruses convert RNA into DNA by the virus-specific enzyme reverse transcriptase (RT). The viral DNA is integrated into the DNA of infected cells of the immune system in such a way that the virus can replicate. Most of the antiviral activity Lopimune, Kaletra, Aluvia (lopinavir and Ritonavir tablet) is due lopinavir, which is a potent inhibitor of HIV protease and prevents cleavage of the polyprotein Gag-Pol, an important protein in the development of active virus Viral splits protease enzyme (destroys) Gag-Pol polyprotein during the final stages of the replication cycle so that the mature fully active virus may be released to infect new cells. Inhibition of the protease cleavage Lopimune, Kaletra, Aluvia (lopinavir and Ritonavir tablet) results in immature, noninfectious virus particles. Ritonavir Lopimune, Kaletra, Aluvia (lopinavir and Ritonavir tablet) includes in combination, not as a protease inhibitor, but because it inhibits CYP3A-mediated metabolism (decomposition in the liver) lopinavir, thereby increasing levels of lopinavir plasma so that lopinavir can be used at a lower dose. Lopimune, Kaletra, Aluvia (lopinavir and ritonavir tablets) used in combination with other retrovirals, which have a different mechanism of action, both emtricitabine and tenofovir as nucleoside reverse transcriptase inhibitors (NRTI), which work by blocking RT action by inhibiting viral replication. The combined effect of lopinavir and ritonavir Lopimune, Kaletra, Aluvia (lopinavir and Ritonavir tablet) in combination with other retroviruses, inhibits the production of active HIV so that viral load (the amount of virus) decreases. Lopimune, Kaletra, Aluvia (lopinavir and ritonavir tablets) slow down the replication of HIV in your body, but does not kill the virus is already included in the CD4 + cells or prevent the spread of infection to others.

1 review for Lopimune Lopinavir + Ritonavir

  1. Rated 1 out of 5

    MichlMeree

    Дома есть интернет, продайте часть своего трафика и получи деньги через 15 – 20 мин!Подробнее….

Add a review

Your email address will not be published.